Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Clovis Oncology, Inc. CLVS

Set alert

Price alert · CLVS

All alert types
0.08 +0.08 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
11.77M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-0.10
Beta
0.22
Short ratio
4.63
Inst. own
25.90%
Dividend
0.00
Ex-div date
Earnings
Nov 9, 2022
50-d avg
0.517402
200-d avg
1.26
1y target
2.00

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Nov 9, 2022Earnings: —; estimate -0.42; surprise —%
  • Nov 10, 2022Downgrade: JP Morgan · Neutral → Underweight
Signals (12)
NameDateAgo
RSI: OversoldDec 5, 20223 years ago
MACD: Buy SignalNov 28, 20223 years ago
RSI: OversoldNov 9, 20223 years ago
MACD: Sell SignalOct 31, 20224 years ago
MACD: Buy SignalOct 28, 20224 years ago
MACD: Sell SignalOct 24, 20224 years ago
MACD: Buy SignalOct 17, 20224 years ago
MACD: Sell SignalOct 12, 20224 years ago
SMA: BearishOct 7, 20224 years ago
SMA: BullishOct 3, 20224 years ago
MACD: Buy SignalSep 29, 20224 years ago
MACD: Sell SignalSep 26, 20224 years ago

Valuation

P/E -1.2×
FY 2012: -5.4×FY 2013: -20.4×FY 2014: -11.9×FY 2015: -3.6×FY 2016: -4.9×FY 2017: -9.2×FY 2018: -2.5×FY 2019: -1.4×FY 2020: -1.1×FY 2021: -1.2×
FY 2012 5y median -1.4× FY 2021
P/S 2.2×
FY 2012: 0.0×FY 2013: 0.0×FY 2014: 139×FY 2015: 0.0×FY 2016: 21913×FY 2017: 57.6×FY 2018: 9.8×FY 2019: 3.9×FY 2020: 2.5×FY 2021: 2.2×
FY 2012 5y median 3.9× FY 2021
P/B -1.2×
FY 2012: 3.0×FY 2013: 3.5×FY 2014: 5.7×FY 2015: 4.2×FY 2016: -470×FY 2017: 8.7×FY 2018: 6.4×FY 2019: -3.2×FY 2020: -2.5×FY 2021: -1.2×
FY 2012 5y median -1.2× FY 2021
P/FCF -1.7×
FY 2012: -6.0×FY 2013: -24.1×FY 2014: -15.9×FY 2015: -4.9×FY 2016: -6.4×FY 2017: -12.1×FY 2018: -2.2×FY 2019: -1.6×FY 2020: -1.5×FY 2021: -1.7×
FY 2012 5y median -1.7× FY 2021
EV/EBITDA -7.2×
FY 2012: -1.8×FY 2013: -8.4×FY 2014: -5.4×FY 2015: -2.2×FY 2016: -6.3×FY 2017: -13.1×FY 2018: -3.9×FY 2019: 23.0×FY 2020: -2.4×FY 2021: -7.2×
FY 2012 5y median -3.9× FY 2021
EV/Sales 5.5×
FY 2012: 0.0×FY 2013: 0.0×FY 2014: 125×FY 2015: 0.0×FY 2016: 23386×FY 2017: 56.1×FY 2018: 13.5×FY 2019: 7.6×FY 2020: 4.9×FY 2021: 5.5×
FY 2012 5y median 7.6× FY 2021
FCF Yield -59.8%
FY 2012: -16.7%FY 2013: -4.2%FY 2014: -6.3%FY 2015: -20.3%FY 2016: -15.6%FY 2017: -8.3%FY 2018: -46.0%FY 2019: -61.0%FY 2020: -64.5%FY 2021: -59.8%
FY 2012 5y median -59.8% FY 2021

Profitability

Gross Margin 73.9%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: -1063.0%FY 2015: 0.0%FY 2016: 10.3%FY 2017: 78.9%FY 2018: 76.9%FY 2019: 75.7%FY 2020: 74.9%FY 2021: 73.9%
FY 2012 5y median 75.7% FY 2021
Operating Margin -156.8%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: -1163.0%FY 2015: 0.0%FY 2016: -477862.8%FY 2017: -428.1%FY 2018: -350.0%FY 2019: -263.4%FY 2020: -183.7%FY 2021: -156.8%
FY 2012 5y median -263.4% FY 2021
Net Margin -177.8%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: -1174.5%FY 2015: 0.0%FY 2016: -447611.5%FY 2017: -624.0%FY 2018: -385.8%FY 2019: -280.0%FY 2020: -224.4%FY 2021: -177.8%
FY 2012 5y median -280.0% FY 2021
ROE 94.9%
FY 2012: -55.4%FY 2013: -17.0%FY 2014: -48.3%FY 2015: -117.4%FY 2016: 9607.5%FY 2017: -94.2%FY 2018: -251.3%FY 2019: 229.8%FY 2020: 232.6%FY 2021: 94.9%
FY 2012 5y median 94.9% FY 2021
ROIC -66.3%
FY 2012: -55.1%FY 2013: -13.3%FY 2014: -21.5%FY 2015: -54.6%FY 2016: -114.2%FY 2017: -36.0%FY 2018: -45.2%FY 2019: -69.5%FY 2020: -70.8%FY 2021: -66.3%
FY 2012 5y median -66.3% FY 2021
ROA -55.9%
FY 2012: -50.7%FY 2013: -13.0%FY 2014: -20.4%FY 2015: -49.5%FY 2016: -95.8%FY 2017: -47.1%FY 2018: -42.6%FY 2019: -59.8%FY 2020: -61.0%FY 2021: -55.9%
FY 2012 5y median -55.9% FY 2021

Growth (YoY)

Revenue -9.6%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: -100.0%FY 2016: 0.0%FY 2017: 71067.9%FY 2018: 71.8%FY 2019: 49.9%FY 2020: 15.0%FY 2021: -9.6%
FY 2012 FY 2021
Operating Income 22.8%
FY 2012: -35.2%FY 2013: -13.5%FY 2014: -89.2%FY 2015: -137.7%FY 2016: 1.1%FY 2017: 36.2%FY 2018: -40.5%FY 2019: -12.9%FY 2020: 19.8%FY 2021: 22.8%
FY 2012 FY 2021
EPS (diluted) 50.2%
FY 2012: 93.1%FY 2013: 0.7%FY 2014: -60.0%FY 2015: -107.4%FY 2016: 7.4%FY 2017: 18.9%FY 2018: 3.9%FY 2019: -5.1%FY 2020: 41.0%FY 2021: 50.2%
FY 2012 FY 2021
Free Cash Flow 24.8%
FY 2012: -65.0%FY 2013: -8.1%FY 2014: -66.1%FY 2015: -114.6%FY 2016: -4.4%FY 2017: 0.9%FY 2018: -62.4%FY 2019: 20.4%FY 2020: 23.8%FY 2021: 24.8%
FY 2012 FY 2021

Financial Health

Current Ratio 1.6×
FY 2012: 11.9×FY 2013: 15.7×FY 2014: 10.3×FY 2015: 7.1×FY 2016: 4.3×FY 2017: 7.7×FY 2018: 4.6×FY 2019: 2.8×FY 2020: 1.7×FY 2021: 1.6×
FY 2012 5y median 2.8× FY 2021
Quick Ratio 1.5×
FY 2012: 11.9×FY 2013: 15.7×FY 2014: 10.3×FY 2015: 7.1×FY 2016: 4.3×FY 2017: 7.4×FY 2018: 4.3×FY 2019: 2.6×FY 2020: 1.5×FY 2021: 1.5×
FY 2012 5y median 2.6× FY 2021
Debt / Equity -2.3×
FY 2012: 0.0×FY 2013: 0.0×FY 2014: 0.9×FY 2015: 1.8×FY 2016: -91.1×FY 2017: 1.0×FY 2018: 3.9×FY 2019: -3.9×FY 2020: -4.1×FY 2021: -2.3×
FY 2012 5y median -2.3× FY 2021
Net Debt / EBITDA -4.3×
FY 2012: 1.0×FY 2013: 1.9×FY 2014: 0.6×FY 2015: -0.4×FY 2016: -0.4×FY 2017: 0.3×FY 2018: -1.1×FY 2019: 11.1×FY 2020: -1.2×FY 2021: -4.3×
FY 2012 5y median -1.1× FY 2021
Interest Coverage -7.4×
FY 2012: 0.0×FY 2013: 0.0×FY 2014: -60.9×FY 2015: -45.0×FY 2016: -43.9×FY 2017: -22.8×FY 2018: -25.3×FY 2019: -22.8×FY 2020: -12.9×FY 2021: -7.4×
FY 2012 5y median -22.8× FY 2021

Dividends

Dividend Yield 0.0%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2012 5y median 0.0% FY 2021
Payout Ratio 0.0%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2012 5y median 0.0% FY 2021

Annual · latest fiscal year ends 2021-12-31